{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:39Z","timestamp":1790697999372,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/cgt.2013.25","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T10:17:14Z","timestamp":1369390634000},"page":"336-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model"],"prefix":"10.1038","volume":"20","author":[{"given":"D","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H E","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Kells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Forsayeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Bankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"BFcgt201325_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/jns.1998.88.1.0001","volume":"88","author":"FG Davis","year":"1998","unstructured":"Davis FG, Freels S, Grutsch J, Barlas S, Brem S . Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88: 1\u201310.","journal-title":"J Neurosurg"},{"key":"BFcgt201325_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1056\/NEJM200101113440207","volume":"344","author":"LM DeAngelis","year":"2001","unstructured":"DeAngelis LM . Brain tumors. N Engl J Med 2001; 344: 114\u2013123.","journal-title":"N Engl J Med"},{"key":"BFcgt201325_CR3","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1073\/pnas.97.12.6242","volume":"97","author":"EC Holland","year":"2000","unstructured":"Holland EC . Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 2000; 97: 6242\u20136244.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201325_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/07357909609076900","volume":"14","author":"AA Brandes","year":"1996","unstructured":"Brandes AA, Fiorentino MV . The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest 1996; 14: 551\u2013559.","journal-title":"Cancer Invest"},{"key":"BFcgt201325_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/cncr.20073","volume":"100","author":"P Hau","year":"2004","unstructured":"Hau P, Fabel K, Baumgart U, Rummele P, Grauer O, Bock A et al. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 2004; 100: 1199\u20131207.","journal-title":"Cancer"},{"key":"BFcgt201325_CR6","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3171\/foc.2006.20.1.8","volume":"20","author":"W Wang","year":"2006","unstructured":"Wang W, Tai CK, Kershaw AD, Solly SK, Klatzmann D, Kasahara N et al. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model. Neurosurg Focus 2006; 20: E25.","journal-title":"Neurosurg Focus"},{"key":"BFcgt201325_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ymthe.2005.03.017","volume":"12","author":"CK Tai","year":"2005","unstructured":"Tai CK, Wang WJ, Chen TC, Kasahara N . Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 2005; 12: 842\u2013851.","journal-title":"Mol Ther"},{"key":"BFcgt201325_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/neuonc\/nor199","volume":"14","author":"D Ostertag","year":"2012","unstructured":"Ostertag D, Amundson KK, Lopez Espinoza F, Martin B, Buckley T, Galvao da Silva AP et al. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector. Neuro Oncol 2012; 14: 145\u2013159.","journal-title":"Neuro Oncol"},{"key":"BFcgt201325_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10495-011-0639-4","volume":"16","author":"A Sgorbissa","year":"2011","unstructured":"Sgorbissa A, Tomasella A, Potu H, Manini I, Brancolini C, Type I . IFNs signaling and apoptosis resistance in glioblastoma cells. Apoptosis 2011; 16: 1229\u20131244.","journal-title":"Apoptosis"},{"key":"BFcgt201325_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2011.02.037","volume":"306","author":"S Amano","year":"2011","unstructured":"Amano S, Gu C, Koizumi S, Tokuyama T, Namba H . Tumoricidal bystander effect in the suicide gene therapy using mesenchymal stem cells does not injure normal brain tissues. Cancer letters 2011; 306: 99\u2013105.","journal-title":"Cancer letters"},{"key":"BFcgt201325_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF00873963","volume":"12","author":"MH Huber","year":"1994","unstructured":"Huber MH, Shirinian M, Lippman SM, Dimery IW, Frankenthaler RA, Hong WK . Phase I\/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck. Invest New Drugs 1994; 12: 223\u2013229.","journal-title":"Invest New Drugs"},{"key":"BFcgt201325_CR12","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1200\/JCO.2003.21.13.2508","volume":"21","author":"FF Lang","year":"2003","unstructured":"Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003; 21: 2508\u20132518.","journal-title":"J Clin Oncol"},{"key":"BFcgt201325_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","volume":"60","author":"W Walther","year":"2000","unstructured":"Walther W, Stein U . Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 2000; 60: 249\u2013271.","journal-title":"Drugs"},{"key":"BFcgt201325_CR14","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","volume":"91","author":"RH Bobo","year":"1994","unstructured":"Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH . Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994; 91: 2076\u20132080.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201325_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymthe.2006.02.018","volume":"14","author":"P Hadaczek","year":"2006","unstructured":"Hadaczek P, Yamashita Y, Mirek H, Tamas L, Bohn MC, Noble C et al. The \"perivascular pump\" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 2006; 14: 69\u201378.","journal-title":"Mol Ther"},{"key":"BFcgt201325_CR16","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","volume":"70","author":"JL Eberling","year":"2008","unstructured":"Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS et al. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 2008; 70: 1980\u20131983.","journal-title":"Neurology"},{"key":"BFcgt201325_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003; 9: 589\u2013595.","journal-title":"Nat Med"},{"key":"BFcgt201325_CR18","first-page":"105","volume":"88","author":"S Kunwar","year":"2003","unstructured":"Kunwar S . Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl 2003; 88: 105\u2013111.","journal-title":"Acta Neurochir Suppl"},{"key":"BFcgt201325_CR19","first-page":"4971","volume":"61","author":"Y Mardor","year":"2001","unstructured":"Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 2001; 61: 4971\u20134973.","journal-title":"Cancer Res"},{"key":"BFcgt201325_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1227\/01.NEU.0000325491.89984.CE","volume":"63","author":"RM Richardson","year":"2008","unstructured":"Richardson RM, Larson PS, Bankiewicz KS . Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery 2008; 63: 629\u2013442.","journal-title":"Neurosurgery"},{"key":"BFcgt201325_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/mt.2012.83","volume":"20","author":"OD Perez","year":"2012","unstructured":"Perez OD, Logg CR, Hiraoka K, Diago O, Burnett R, Inagaki A et al. Design and selection of toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression. Mol Ther 2012; 20: 1689\u20131698.","journal-title":"Mol Ther"},{"key":"BFcgt201325_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1006\/exnr.2000.7408","volume":"164","author":"KS Bankiewicz","year":"2000","unstructured":"Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J et al. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol 2000; 164: 2\u201314.","journal-title":"Exp Neurol"},{"key":"BFcgt201325_CR23","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1158\/0008-5472.CAN-04-1683","volume":"64","author":"R Saito","year":"2004","unstructured":"Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS et al. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res 2004; 64: 6858\u20136862.","journal-title":"Cancer Res"},{"key":"BFcgt201325_CR24","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1158\/0008-5472.CAN-03-3631","volume":"64","author":"R Saito","year":"2004","unstructured":"Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC et al. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 2004; 64: 2572\u20132579.","journal-title":"Cancer Res"},{"key":"BFcgt201325_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneumeth.2009.12.008","volume":"187","author":"D Yin","year":"2010","unstructured":"Yin D, Forsayeth J, Bankiewicz KS . Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods 2010; 187: 46\u201351.","journal-title":"J Neurosci Methods"},{"key":"BFcgt201325_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4419-6306-2_20","volume":"678","author":"PM Wigmore","year":"2010","unstructured":"Wigmore PM, Mustafa S, El-Beltagy M, Lyons L, Umka J, Bennett G . Effects of 5-FU. Adv Exp Med Biol 2010; 678: 157\u2013164.","journal-title":"Adv Exp Med Biol"},{"key":"BFcgt201325_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00006123-199607000-00023","volume":"39","author":"P Menei","year":"1996","unstructured":"Menei P, Boisdron-Celle M, Croue A, Guy G, Benoit JP . Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 1996; 39: 117\u2013123.","journal-title":"Neurosurgery"},{"key":"BFcgt201325_CR28","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/cncr.11388","volume":"97","author":"E Fournier","year":"2003","unstructured":"Fournier E, Passirani C, Montero-Menei C, Colin N, Breton P, Sagodira S et al. Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer 2003; 97: 2822\u20132829.","journal-title":"Cancer"},{"key":"BFcgt201325_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0168-3659(99)00250-3","volume":"65","author":"JP Benoit","year":"2000","unstructured":"Benoit JP, Faisant N, Venier-Julienne MC, Menei P . Development of microspheres for neurological disorders: from basics to clinical applications. J Control Release 2000; 65: 285\u2013296.","journal-title":"J Control Release"},{"key":"BFcgt201325_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/hum.2011.220","volume":"23","author":"G Mittermeyer","year":"2012","unstructured":"Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P et al. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson\u2019s Disease. Hum Gene Ther 2012; 23: 377\u2013381.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201325_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000323544","volume":"89","author":"RM Richardson","year":"2011","unstructured":"Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, Piferi PG et al. Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg 2011; 89: 141\u2013151.","journal-title":"Stereotact Funct Neurosurg"},{"key":"BFcgt201325_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.expneurol.2005.08.016","volume":"196","author":"R Saito","year":"2005","unstructured":"Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P et al. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 2005; 196: 381\u2013389.","journal-title":"Exp Neurol"},{"key":"BFcgt201325_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresprot.2005.08.003","volume":"16","author":"MT Krauze","year":"2005","unstructured":"Krauze MT, McKnight TR, Yamashita Y, Bringas J, Noble CO, Saito R et al. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc 2005; 16: 20\u201326.","journal-title":"Brain Res Brain Res Protoc"},{"key":"BFcgt201325_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.nurt.2007.10.064","volume":"5","author":"MS Fiandaca","year":"2008","unstructured":"Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS . Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008; 5: 123\u2013127.","journal-title":"Neurotherapeutics"},{"key":"BFcgt201325_CR35","first-page":"46","volume":"187","author":"D Yin","year":"2009","unstructured":"Yin D, Valles FE, Fiandaca MS, Bringas J, Gimenez F, Berger MS et al. Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage 2009; 187: 46\u201351.","journal-title":"Neuroimage"},{"key":"BFcgt201325_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3171\/2010.2.JNS091744","volume":"113","author":"D Yin","year":"2010","unstructured":"Yin D, Richardson RM, Fiandaca MS, Bringas J, Forsayeth J, Berger MS et al. Cannula placement for effective convection-enhanced delivery in the non-human primate thalamus and brainstem: Implications for clinical delivery of therapeutics. J Neurosurg 2010; 113: 240\u2013248.","journal-title":"J Neurosurg"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201325","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:10:06Z","timestamp":1647951006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFcgt201325"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2013.25","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]},"assertion":[{"value":"4 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Harry Gruber, Carlos Ibanez, Joan Robbins and Douglas Jolly are employees of Tocagen, which funded this study. Noriyuki Kasahara is a consultant and co-founder of Tocagen and has received research support from the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}